Pei Liu

938 citations
30 papers · 735 indexed · h-index 13
Topics
Cancer-related molecular mechanisms research (10 papers)MicroRNA in disease regulation (6 papers)RNA modifications and cancer (6 papers)
Partner nations
ChinaAustraliaCanada

In The Last Decade

Pei Liu

30 papers receiving 731 citations

Peers

Pei Liu
Comparison fields: 5 of 93
  • Molecular Biology 379
  • Cancer Research 193
  • Oncology 131
  • Immunology 120
  • Cellular and Molecular Neuroscience 101
Replace Jiean Huang with:
Jiean Huang China
Zhiming Yang China
Lin Sun China
Zhu‐Qin Zhang China
Sabira Mohammed United States
Dominic Jones United Kingdom
Zeyang Li China
Baolin Liu China
Tatsunori Mizuno Japan
Shashi Kant United States
Pei Liu relative to Jiean Huang China Jiean Huang's profile →
Citations per field
00.5×1.5×
Jiean Huang · 1×
Citations per year

Countries citing papers authored by Pei Liu

Since Specialization
Citations

This map shows the geographic impact of Pei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Liu more than expected).

Fields of papers citing papers by Pei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Liu. The network helps show where Pei Liu may publish in the future.

Co-authorship network of co-authors of Pei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Liu. A scholar is included among the top collaborators of Pei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Liu. Pei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 3
3 12
4 2
5 10
6 1
7 7
8 17
9 73
10 14
11 23
12 29
13 5
14 35
15 57
16 123
17 3
18
Inhibitory effects of sesquiterpenes from Common Aucklandia Root on proliferation of five kinds cultured cancer cells in vitro
3
19 104
20
17β-Estradiol inhibits vascular smooth muscle cell proliferation and c-fos expression: role of nitric oxide
1

About Pei Liu

Pei Liu is a scholar working on Cancer Research, Clinical Biochemistry and Oncology, having authored 30 papers that have together received 735 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Cancer Research (193 citations), Neurology (53 citations) and Cell Biology (95 citations). Pei Liu has collaborated with scholars based in China, Australia and Canada. Frequent co-authors include Wei Cui, Lixin Li, Sa Lv, Wen Wang, Hongli Song, Ying Zhou, Yan Zhang, Feng Zhu, Xiufei Gao and Philippe Lemieux. Their work appears in journals such as Nature Neuroscience, The FASEB Journal and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026